27317610|t|Diffuse traumatic brain injury affects chronic corticosterone function in the rat
27317610|a|As many as 20-55% of patients with a history of traumatic brain injury (TBI) experience chronic endocrine dysfunction, leading to impaired quality of life, impaired rehabilitation efforts and lowered life expectancy. Endocrine dysfunction after TBI is thought to result from acceleration - deceleration forces to the brain within the skull, creating enduring hypothalamic and pituitary neuropathology, and subsequent hypothalamic -pituitary endocrine (HPE) dysfunction. These experiments were designed to test the hypothesis that a single diffuse TBI results in chronic dysfunction of corticosterone (CORT), a glucocorticoid released in response to stress and testosterone. We used a rodent model of diffuse TBI induced by midline fluid percussion injury (mFPI). At 2 months postinjury compared with uninjured control animals, circulating levels of CORT were evaluated at rest, under restraint stress and in response to dexamethasone, a synthetic glucocorticoid commonly used to test HPE axis regulation. Testosterone was evaluated at rest. Further, we assessed changes in injury - induced neuron morphology (Golgi stain), neuropathology (silver stain) and activated astrocytes (GFAP) in the paraventricular nucleus (PVN) of the hypothalamus. Resting plasma CORT levels were decreased at 2 months postinjury and there was a blunted CORT increase in response to restraint induced stress. No changes in testosterone were measured. These changes in CORT were observed concomitantly with altered complexity of neuron processes in the PVN over time, devoid of neuropathology or astrocytosis. Results provide evidence that a single moderate diffuse TBI leads to changes in CORT function, which can contribute to the persistence of symptoms related to endocrine dysfunction. Future experiments aim to evaluate additional HP-related hormones and endocrine circuit pathology following diffuse TBI.
27317610	0	30	Diffuse traumatic brain injury	T037	C2832047
27317610	39	46	chronic	T079	C0205191
27317610	47	61	corticosterone	T109,T121,T125	C0010124
27317610	62	70	function	T169	C0542341
27317610	78	81	rat	T015	C0034721
27317610	103	111	patients	T101	C0030705
27317610	119	126	history	T033	C0332119
27317610	130	152	traumatic brain injury	T037	C0876926
27317610	154	157	TBI	T037	C0876926
27317610	170	177	chronic	T079	C0205191
27317610	178	199	endocrine dysfunction	T047	C1397856
27317610	212	236	impaired quality of life	T054	C4049260
27317610	238	246	impaired	T169	C0221099
27317610	247	261	rehabilitation	T169	C0034992
27317610	262	269	efforts	T051	C1516084
27317610	274	297	lowered life expectancy	T033	C1504437
27317610	299	320	Endocrine dysfunction	T047	C1397856
27317610	327	330	TBI	T037	C0876926
27317610	345	351	result	T169	C1274040
27317610	357	369	acceleration	T067	C0000894
27317610	372	384	deceleration	T070	C0011100
27317610	385	391	forces	T067	C0441722
27317610	399	404	brain	T023	C0006104
27317610	416	421	skull	T023	C2951888
27317610	441	453	hypothalamic	T023	C0020663
27317610	458	467	pituitary	T023	C0032005
27317610	468	482	neuropathology	T046	C1540677
27317610	499	511	hypothalamic	T023	C0020663
27317610	499	532	hypothalamic -pituitary endocrine	T022	C0014136
27317610	534	537	HPE	T022	C0014136
27317610	539	550	dysfunction	T046	C0277785
27317610	558	569	experiments	T062	C0681814
27317610	596	606	hypothesis	T078	C1512571
27317610	621	632	diffuse TBI	T037	C2832047
27317610	633	640	results	T169	C1274040
27317610	644	651	chronic	T079	C0205191
27317610	652	663	dysfunction	T046	C0277785
27317610	667	681	corticosterone	T109,T121,T125	C0010124
27317610	683	687	CORT	T109,T121,T125	C0010124
27317610	692	706	glucocorticoid	T109,T125	C0017710
27317610	707	715	released	T169	C0391871
27317610	731	737	stress	T046	C0449430
27317610	742	754	testosterone	T109,T121,T125	C0039601
27317610	766	778	rodent model	T050	C1519106
27317610	782	793	diffuse TBI	T037	C2832047
27317610	805	836	midline fluid percussion injury	T037	C3714660
27317610	838	842	mFPI	T037	C3714660
27317610	850	856	months	T079	C0439231
27317610	857	867	postinjury	T079	C1254367
27317610	868	876	compared	T052	C1707455
27317610	882	907	uninjured control animals	T008	C1511501
27317610	909	920	circulating	T169	C0175630
27317610	921	927	levels	T080	C0441889
27317610	931	935	CORT	T109,T121,T125	C0010124
27317610	951	958	at rest	T169	C0443144
27317610	966	982	restraint stress	T046	C0449430
27317610	1002	1015	dexamethasone	T109,T121	C0011777
27317610	1019	1043	synthetic glucocorticoid	T109,T121	C0017711
27317610	1066	1069	HPE	T022	C0014136
27317610	1070	1074	axis	T082	C1522496
27317610	1075	1085	regulation	T038	C1327622
27317610	1087	1099	Testosterone	T109,T121,T125	C0039601
27317610	1104	1113	evaluated	T169	C1292732
27317610	1114	1121	at rest	T169	C0443144
27317610	1144	1151	changes	T169	C0392747
27317610	1155	1161	injury	T037	C3714660
27317610	1164	1171	induced	T169	C0205263
27317610	1172	1178	neuron	T025	C0027882
27317610	1179	1189	morphology	T080	C0332437
27317610	1191	1202	Golgi stain	T059	C0487602
27317610	1205	1219	neuropathology	T046	C1540677
27317610	1221	1233	silver stain	T059	C0487602
27317610	1239	1248	activated	T043	C1326120
27317610	1249	1259	astrocytes	T025	C0004112
27317610	1261	1265	GFAP	T059	C0487602
27317610	1274	1297	paraventricular nucleus	T023	C0030532
27317610	1299	1302	PVN	T023	C0030532
27317610	1311	1323	hypothalamus	T023	C0020663
27317610	1333	1339	plasma	T031	C0032105
27317610	1340	1344	CORT	T109,T121,T125	C0010124
27317610	1345	1351	levels	T080	C0441889
27317610	1357	1366	decreased	T081	C0205216
27317610	1372	1378	months	T079	C0439231
27317610	1379	1389	postinjury	T079	C1254367
27317610	1414	1418	CORT	T109,T121,T125	C0010124
27317610	1419	1427	increase	T081	C0205217
27317610	1443	1467	restraint induced stress	T046	C0449430
27317610	1469	1479	No changes	T033	C0442739
27317610	1483	1495	testosterone	T109,T121,T125	C0039601
27317610	1501	1509	measured	T080	C0444706
27317610	1517	1524	changes	T169	C0392747
27317610	1528	1532	CORT	T109,T121,T125	C0010124
27317610	1547	1560	concomitantly	T079	C0521115
27317610	1566	1573	altered	T169	C0392747
27317610	1574	1584	complexity	T080	C0439855
27317610	1588	1594	neuron	T025	C0027882
27317610	1595	1604	processes	T043	C0007613
27317610	1612	1615	PVN	T023	C0030532
27317610	1621	1625	time	T079	C0040223
27317610	1637	1651	neuropathology	T046	C1540677
27317610	1655	1667	astrocytosis	T046	C3887640
27317610	1669	1676	Results	T169	C1274040
27317610	1717	1728	diffuse TBI	T037	C2832047
27317610	1738	1745	changes	T169	C0392747
27317610	1749	1753	CORT	T109,T121,T125	C0010124
27317610	1754	1762	function	T169	C0542341
27317610	1792	1815	persistence of symptoms	T033	C0518691
27317610	1827	1848	endocrine dysfunction	T047	C1397856
27317610	1857	1868	experiments	T062	C0681814
27317610	1876	1884	evaluate	T169	C1292732
27317610	1896	1915	HP-related hormones	T125	C0019932
27317610	1920	1929	endocrine	T022	C0014136
27317610	1930	1947	circuit pathology	T169	C0205469
27317610	1958	1969	diffuse TBI	T037	C2832047